scorecardresearch
Add as a preferred source on Google
Tuesday, September 23, 2025
TopicOxford University

Topic: Oxford University

AstraZeneca-Oxford Covid vaccine produces strong immune response in older adults

The Astra-Oxford vaccine candidate is one of several front-runners in the race for protection against the virus.

AstraZeneca resumes Covid-19 vaccine trial in Japan, US still on hold

The phase 1 and 2 trials resumed after the Japanese regulator gave the go-ahead. Trials in the UK, Brazil, South Africa and India had already restarted in recent weeks.

RECOVERY trial to test REGN-COV2, first specifically designed antibody cocktail for Covid

The RECOVERY trial, the world's largest trial, is currently looking for therapeutic options against Covid.

Still aiming for Oxford Covid vaccine by end of this year, AstraZeneca CEO says

AstraZeneca CEO Pascal Soriot sought to reassure investors after the Oxford vaccine trial was halted due to a person in the UK falling sick, triggering a review of safety data.

Delay of AstraZeneca’s Covid vaccine could be painful but it’s responsible

The AstraZeneca Plc paused the trial of its leading candidate, developed with Oxford University, to study a volunteer's illness. This pause shows the system is working as it should.

Oxford’s new Covid vaccine begins human trials in partnership with Serum Institute of India

Serum Institute of India, the world’s largest vaccine manufacturer, will run trials of the shot developed by SpyBiotech that uses a patented superglue tech to induce an immune response.

Oxford Covid vaccine given to 2 volunteers as Serum Institute begins human trials in India

The Phase 2 trials began in Pune's Bharati Vidyapeeth Medical College and Hospital. A total of 25 volunteers will be enrolled at the hospital.

Oxford vaccine human trial in India a step closer as panel clears Serum Institute protocol 

The protocol will now be moved to DCGI V.G. Somani, who is likely to take a ‘decision by the end of the week’ given the urgency of the Covid challenge.

SII proposes 1,600 subjects in 20 Indian cities for Oxford vaccine trials, govt to decide today

India’s apex clinical trial regulation body will meet urgently to reconsider Serum Institute of India’s proposal after it revised its plan for starting Oxford vaccine's human trials in India.

Two Asian pharma companies hold key to Oxford vaccine, China woos ASEAN & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

On Camera

Bads of Bollywood can’t get more brazenly nepo. The joke’s on us

After watching the most discussed series on Netflix, I was planning to write an asterisk-heavy column. As a tribute to the asterisks in its...

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

China navy achieves breakthrough with new fighter jet launch system. What are electromagnetic catapults

China’s most advanced aircraft carrier—Fujian—uses electromagnetic catapults, a core component of future aircraft carriers.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.